Juliane Ollinger

Statistics

Publications

Citations

1.3K

H-Index

Active since

2006

Affiliations

Infectious Disease Research Institute(Current)

Eli Lilly (United States)

Cornell University

University of Notre Dame

National Institutes of Health

Juliane Ollinger is an author at Infectious Disease Research Institute specializing in drug discovery, mycobacterium tuberculosis infection, and pharmacology.

Publications per year

2006–2019

Publications

Role of the Fur Regulon in Iron Transport in Bacillus subtilis

Juliane Ollinger, Kyung-Bok Song, Haike Antelmann et al. · Journal of Bacteriology · 2006 · 216 citations · Full text

Life Sciences, Genetics, Microbiology +14

A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis

Juliane Ollinger, Mai A. Bailey, Garrett C. Moraski et al. · PLoS ONE · 2013 · 177 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target

Juliane Ollinger, Theresa O’Malley, Edward A. Kesicki et al. · Journal of Bacteriology · 2011 · 133 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis

Garrett C. Moraski, Lowell D. Markley, Jeffrey W. Cramer et al. · ACS Medicinal Chemistry Letters · 2013 · 112 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Transcriptomic and Phenotypic Analyses Identify Coregulated, Overlapping Regulons among PrfA, CtsR, HrcA, and the Alternative Sigma Factors σ B , σ C , σ H , and σ L in Listeria monocytogenes

Soraya Chaturongakul, Sarita Raengpradub, M. Elizabeth Palmer et al. · Applied and Environmental Microbiology · 2010 · 110 citations · Full text

Life Sciences, Genetics, Microbiology +17

1–5 of 19